Frontiers in Microbiology

SEP 3, 2026 · JOURNAL ARTICLE

Gut microbiota–host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies

Frontiers in Microbiology

This is a systematic review synthesizing mechanistic knowledge and therapeutic evidence to provide a conceptual framework for understanding microbiota–immune interactions in T2DM and guiding future research and clinical translation strategies.

SEP 1, 2026 · JOURNAL ARTICLE

Quorum sensing gene abaI enhancing capsule production and pathogenicity of Acinetobacter baumannii

Frontiers in Microbiology

Mechanistic study in knockout bacteria and mouse models identifying a QS gene's role in virulence; lacks clinical outcome data and remains exploratory regarding therapeutic translation.

AUG 28, 2026 · JOURNAL ARTICLE

Genomic surveillance reveals escalating antimicrobial resistance and plasmid diversity in clinical Salmonella 1,4,[5],12:i:- ST34 isolates from Guizhou Province, China

Frontiers in Microbiology

A 5-year genomic surveillance study of a single Salmonella serotype in one Chinese province, providing descriptive epidemiology and resistance patterns without a control group or clinical outcomes, useful for understanding local resistance trends but not sufficient to guide practice changes.

AUG 17, 2026 · JOURNAL ARTICLE

Antibiotic resistance in K. pneumoniae: perspectives, challenges, health risks, therapeutic approaches

Frontiers in Microbiology

A narrative review synthesizing existing knowledge on mechanisms, epidemiology, and challenges; raises questions about therapeutic approaches rather than reporting original evidence from a controlled study.

AUG 12, 2026 · JOURNAL ARTICLE

MRSA in Tibet: high prevalence driven by the epidemic clone CC59-ST59-SCCmec IV-t437 and insights from whole-genome analysis

Frontiers in Microbiology

Single-center molecular epidemiology study with WGS characterization of MRSA in a specific population; descriptive findings without a comparator or intervention, providing baseline surveillance data requiring confirmation in larger cohorts.

AUG 11, 2026 · JOURNAL ARTICLE

Genomic epidemiology of the Mycobacterium tuberculosis complex in Fiji reveals community transmission and human Mycobacterium bovis infection

Frontiers in Microbiology

Descriptive genomic epidemiology study of circulating TB strains in a resource-limited setting, without a comparator or intervention, providing characterization of lineages and transmission patterns but no causal or comparative evidence.

AUG 11, 2026 · JOURNAL ARTICLE

Molecular epidemiology of mcr-1-harboring avian pathogenic Escherichia coli from diseased chickens in Shanxi, China (2021–2024)

Frontiers in Microbiology

A descriptive molecular epidemiology survey of 50 isolates from a single Chinese province with no comparator group, control arm, or clinical outcome; establishes local prevalence and resistance patterns but lacks the design and scope to guide practice change.

AUG 6, 2026 · JOURNAL ARTICLE

Integrated gut microbiome and serum lipidomics reveals microbial–lipid interactions for predicting incident metabolic syndrome: a nested case–control study

Frontiers in Microbiology

A sound exploratory nested case–control study with multi-omics integration demonstrating microbial–lipid associations and predictive discrimination; limited by modest sample size, single cohort, and validation-set AUC that falls short of clinical utility.